Norway's Crown Princess Mette-Marit has undergone a life-changing lung transplant after suffering a serious deterioration in her long-running battle with a chronic lung disease, prompting fresh concerns over the health of the future queen.
The Norwegian Royal Palace confirmed that the 52-year-old royal received the transplant at Oslo University Hospital Rikshospitalet after being placed on a transplant waiting list earlier this month. The dramatic development came after doctors determined that her pulmonary fibrosis had progressed to the point where a donor lung was needed.
The surgery marks the most significant escalation yet in Mette-Marit's health struggles since she revealed in 2018 that she had been diagnosed with the incurable condition, which causes scarring of the lungs and makes breathing increasingly difficult over time.
While palace officials said the operation had been successful so far, the Crown Princess now faces a lengthy recovery period and will remain under close medical supervision in the weeks ahead.
The health crisis has also raised questions about her future public duties as she continues her recovery alongside her husband, Crown Prince Haakon, and their family.
Future Queen's Health Took Dramatic Turn
According to The Royal House of Norway, the palace announced on 5 June that Mette-Marit had been placed on Norway's lung transplant waiting list after doctors concluded that her illness had worsened significantly.
For years, the Crown Princess continued carrying out royal engagements despite periodic health setbacks linked to pulmonary fibrosis. However, officials acknowledged that the progression of the disease had become severe enough to affect her ability to work.
The condition causes permanent scarring of lung tissue, reducing the lungs' ability to transfer oxygen into the bloodstream. Although treatments can help manage symptoms, there is no cure, and some patients eventually require a transplant.
Less than two weeks after being added to the waiting list, a suitable donor organ became available.
'The lung transplant has been successful thus far,' said Arnt Fiane, Professor of Medicine at the University of Oslo, cardiothoracic surgeon and head of the Heart and Lung Transplant Programme at Oslo University Hospital Rikshospitalet.
The operation was carried out by a specialist medical team at the hospital, with doctors stressing that the coming weeks remain crucial in monitoring her recovery.
The news prompted an outpouring of support from Norwegians, many of whom have followed Mette-Marit's health journey since her diagnosis became public eight years ago, as CNN reported.
Long Recovery Lies Ahead After Major Surgery
Although the transplant offers renewed hope, medical experts say recovery from lung transplant surgery can be lengthy and demanding.
Patients typically require extensive rehabilitation and lifelong medication to prevent their bodies from rejecting the donor organ. Doctors must also closely monitor recipients for infections and other complications during the months following surgery.
Professor Are Holm, a respiratory specialist at Oslo University Hospital, said the Crown Princess would remain in hospital for several weeks.
'We are delighted that everything has progressed well so far. In accordance with standard practice for all recent transplant recipients, Her Royal Highness the Crown Princess will remain admitted to Oslo University Hospital Rikshospitalet for several weeks to come,' he said.
The palace has not indicated when Mette-Marit may resume official engagements, and Crown Prince Haakon is expected to adjust parts of his schedule while supporting his wife through her recovery.
In a statement released through the Royal Household, the couple expressed gratitude for the support they have received during this difficult period.
'The Crown Prince and the Crown Princess express their sincere gratitude for the many warm and kind messages they have received. This means a great deal to them at this challenging time.'
For now, the future queen's focus remains firmly on recovery. While the successful transplant offers fresh hope after years of declining health, uncertainty remains over how quickly she will return to public life as Norway watches and waits for further updates.
